AFG Fiduciary Services Limited Partnership Sells 5,585 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

AFG Fiduciary Services Limited Partnership cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 64.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,074 shares of the exchange traded fund’s stock after selling 5,585 shares during the period. AFG Fiduciary Services Limited Partnership’s holdings in SPDR S&P Biotech ETF were worth $272,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Healthcare of Ontario Pension Plan Trust Fund boosted its position in SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after purchasing an additional 6,138,000 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of SPDR S&P Biotech ETF in the 3rd quarter worth about $141,284,000. Affinity Asset Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 105.4% during the second quarter. Affinity Asset Advisors LLC now owns 37,550 shares of the exchange traded fund’s stock worth $3,481,000 after buying an additional 737,550 shares during the last quarter. Assetmark Inc. increased its holdings in SPDR S&P Biotech ETF by 72,653.0% during the third quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares during the last quarter. Finally, Sivik Global Healthcare LLC bought a new stake in SPDR S&P Biotech ETF in the third quarter worth about $29,640,000.

SPDR S&P Biotech ETF Stock Up 2.9 %

SPDR S&P Biotech ETF stock opened at $90.51 on Wednesday. The firm has a 50 day moving average price of $93.58 and a 200-day moving average price of $96.95. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The company has a market capitalization of $6.90 billion, a P/E ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.